Keymed Biosciences (HKSE:02162) Days Inventory : 570.96 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Keymed Biosciences Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Keymed Biosciences's Average Total Inventories for the six months ended in Dec. 2023 was HK$74.8 Mil. Keymed Biosciences's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$23.9 Mil. Hence, Keymed Biosciences's Days Inventory for the six months ended in Dec. 2023 was 570.96.

The historical rank and industry rank for Keymed Biosciences's Days Inventory or its related term are showing as below:

HKSE:02162' s Days Inventory Range Over the Past 10 Years
Min: 244.26 Med: 503.69 Max: 4409.9
Current: 601.16

During the past 5 years, Keymed Biosciences's highest Days Inventory was 4409.90. The lowest was 244.26. And the median was 503.69.

HKSE:02162's Days Inventory is ranked worse than
83.92% of 653 companies
in the Biotechnology industry
Industry Median: 190.92 vs HKSE:02162: 601.16

Keymed Biosciences's Days Inventory declined from Dec. 2022 (162,180.52) to Dec. 2023 (570.96).

Inventory Turnover measures how fast the company turns over its inventory within a year. Keymed Biosciences's Inventory Turnover for the six months ended in Dec. 2023 was 0.32.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Keymed Biosciences's Inventory-to-Revenue for the six months ended in Dec. 2023 was 2.54.

Keymed Biosciences Days Inventory Historical Data

The historical data trend for Keymed Biosciences's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Keymed Biosciences Days Inventory Chart

Keymed Biosciences Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

244.26

4,409.90

503.69

Keymed Biosciences Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Inventory	Get a 7-Day Free Trial				194.49	1,981.57	162,180.52	764.79	570.96

Competitive Comparison of Keymed Biosciences's Days Inventory

For the Biotechnology subindustry, Keymed Biosciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Keymed Biosciences's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Keymed Biosciences's Days Inventory distribution charts can be found below:

* The bar in red indicates where Keymed Biosciences's Days Inventory falls into.

Keymed Biosciences Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Keymed Biosciences's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (49.688	+	61.639)	/	2 )	/	40.337	*	365
=	55.6635					/	40.337	*	365
=	503.69

Keymed Biosciences's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (87.974	+	61.639)	/	2 )	/	23.911	*	365 / 2
=	74.8065					/	23.911	*	365 / 2
=	570.96

Keymed Biosciences (HKSE:02162) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Keymed Biosciences's Inventory Turnover for the six months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	23.911	/	74.8065
	=	0.32

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Keymed Biosciences's Inventory to Revenue for the six months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	74.8065	/	29.5
	=	2.54

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Keymed Biosciences Days Inventory Related Terms

Thank you for viewing the detailed overview of Keymed Biosciences's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Keymed Biosciences (HKSE:02162) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Keymed Biosciences Inc (HKSE:02162) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

64Z:Germany

Address

No. 18 BioTown Middle Road, Building D2, Tianfu International BioTown, Chengdu, Sichuan, CHN, 610219

Website

https://www.keymedbio.com

Keymed Biosciences Inc is a biotechnology company with multiple clinical-stage assets. The company is focused on the in-house discovery and development of innovative biological therapies that address large underserved medical needs in the autoimmune and oncology therapeutic areas. The Group is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment. Geographically, it operates in Hong Kong & Mainland China, out of which the majority is from Mainland China.

Keymed Biosciences (HKSE:02162) Headlines

No Headlines